As pharmaceutical industry retreats, research and development for tuberculosis treatments, diagnostics and prevention relies more than ever on government support, and it’s dropping, Treatment Action Group report shows . . . LIVERPOOL, England – The chance to have the right people and the right information in the right place at the same time comes all too rarely […]
LIVERPOOL, England – While much of the focus at this conference focuses on the pursuit of new knowledge, to better treat, diagnose and prevent tuberculosis, a group of experts from leading institutions worldwide have put together everything they currently know about the disease in 23 pages. Among the points, lead author Madhukar Pai said today, as […]
HIV
By Richard Ngethe, MBA, Data.FI As a data clerk in Kenya in 2005, my challenge was to work at rural hospitals digitizing client-level longitudinal data for […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]